Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Jean Saunders

Jean Saunders

University of Limerick, Ireland

Title: The involvement of patients/people in the Design and Development of Clinical Trials within Ireland and Europe

Biography

Biography: Jean Saunders

Abstract

Clinical Trials were originally designed and developed with input from various experts, statisticians, clinicians, nurses etc. Gradually there was a recognition that maybe the patients (or participants) in the actual trial could contribute although at first this was mainly limited to their involvement in the choice of outcome measures. The difficulty of involving patients in clinical trial design was mainly attributed to patients not having sufficient understanding of the trials to be able to make more than simple design changes. However Patients’ Organisations have developed within Ireland and Europe and have become more and more influential at all levels of treatment and health provision. However the patients/organisations still had very little influence over clinical trial design leading to the patients’ organisations criticising the trials when they were taking place or completed. This has led recently to the idea of the ‘expert’ patient. This is the concept that patients often know quite a lot about their disease so the only thing stopping them from providing useful input into a clinical trial is their comparative lack of knowledge of interpreting the medical literature and/or the design of efficient and valid clinical trials. To address this various programmes of education for patients have been devised in Ireland and within Europe training them how to ‘read’ medical papers and understand clinical trials. This talk provides the history behind these initiatives and the (successful) results obtained. Now very few trials are planned in Ireland and the EU without some input from patients or patient groups.